Synektik Spólka Akcyjna (SNT.WA)
PLN 184.4
(-1.91%)
PLN 184.4
(-1.91%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 624.79 Million PLN | 39.82% |
| 2023 | 446.87 Million PLN | 167.84% |
| 2022 | 166.86 Million PLN | 29.72% |
| 2021 | 128.62 Million PLN | 2.59% |
| 2020 | 125.38 Million PLN | -6.97% |
| 2019 | 134.78 Million PLN | 27.97% |
| 2018 | 105.32 Million PLN | 67.35% |
| 2017 | 62.93 Million PLN | 27.32% |
| 2016 | 49.43 Million PLN | -40.87% |
| 2015 | 83.59 Million PLN | 6.23% |
| 2014 | 78.69 Million PLN | 1.7% |
| 2013 | 77.37 Million PLN | 25.91% |
| 2012 | 61.45 Million PLN | 36.33% |
| 2011 | 45.07 Million PLN | 45.29% |
| 2010 | 31.02 Million PLN | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 271.29 Million PLN | 99.87% |
| 2024 Q3 | 123.97 Million PLN | 41.36% |
| 2024 Q2 | 87.7 Million PLN | -67.67% |
| 2023 Q2 | 65.66 Million PLN | -54.34% |
| 2023 Q4 | 135.73 Million PLN | 33.46% |
| 2023 FY | 446.91 Million PLN | 167.84% |
| 2023 Q3 | 101.7 Million PLN | 54.89% |
| 2023 Q1 | 143.81 Million PLN | 146.35% |
| 2022 Q2 | 37.29 Million PLN | 5.29% |
| 2022 Q4 | 58.37 Million PLN | 63.23% |
| 2022 FY | 166.86 Million PLN | 29.72% |
| 2022 Q1 | 35.42 Million PLN | -31.7% |
| 2022 Q3 | 35.76 Million PLN | -4.11% |
| 2021 Q3 | 15.72 Million PLN | -41.71% |
| 2021 Q2 | 26.97 Million PLN | -20.82% |
| 2021 Q1 | 34.06 Million PLN | 19.41% |
| 2021 FY | 128.62 Million PLN | 2.59% |
| 2021 Q4 | 51.86 Million PLN | 229.87% |
| 2020 FY | 125.38 Million PLN | -6.97% |
| 2020 Q4 | 28.52 Million PLN | 28.01% |
| 2020 Q1 | 37.59 Million PLN | 12.12% |
| 2020 Q2 | 36.98 Million PLN | -1.62% |
| 2020 Q3 | 22.28 Million PLN | -39.73% |
| 2019 Q1 | 65.95 Million PLN | 166.42% |
| 2019 FY | 134.78 Million PLN | 27.97% |
| 2019 Q4 | 33.52 Million PLN | 103.23% |
| 2019 Q3 | 16.49 Million PLN | -12.28% |
| 2019 Q2 | 18.8 Million PLN | -71.48% |
| 2018 Q3 | 10.13 Million PLN | 20.65% |
| 2018 FY | 105.32 Million PLN | 67.35% |
| 2018 Q1 | 34.03 Million PLN | 195.53% |
| 2018 Q2 | 8.4 Million PLN | -75.31% |
| 2018 Q4 | 24.75 Million PLN | 144.2% |
| 2017 FY | 62.93 Million PLN | 27.32% |
| 2017 Q1 | 14.19 Million PLN | -3.56% |
| 2017 Q2 | 7.76 Million PLN | -45.34% |
| 2017 Q3 | 9.63 Million PLN | 24.09% |
| 2017 Q4 | 11.51 Million PLN | 19.58% |
| 2016 Q1 | 25.61 Million PLN | -37.43% |
| 2016 Q4 | 14.72 Million PLN | 16.64% |
| 2016 Q3 | 12.62 Million PLN | 59.95% |
| 2016 Q2 | 7.89 Million PLN | -69.19% |
| 2016 FY | 49.43 Million PLN | -40.87% |
| 2015 Q1 | 30.58 Million PLN | 48.07% |
| 2015 FY | 83.59 Million PLN | 6.23% |
| 2015 Q2 | 10.07 Million PLN | -67.05% |
| 2015 Q4 | 40.93 Million PLN | 487.07% |
| 2015 Q3 | 6.97 Million PLN | -30.8% |
| 2014 Q2 | 8.83 Million PLN | -71.5% |
| 2014 Q1 | 31 Million PLN | 28.45% |
| 2014 Q3 | 18.62 Million PLN | 110.78% |
| 2014 Q4 | 20.65 Million PLN | 10.9% |
| 2014 FY | 78.69 Million PLN | 1.7% |
| 2013 Q2 | 11.89 Million PLN | -58.79% |
| 2013 Q4 | 24.13 Million PLN | 133.42% |
| 2013 FY | 77.37 Million PLN | 25.91% |
| 2013 Q3 | 10.33 Million PLN | -13.11% |
| 2013 Q1 | 28.87 Million PLN | 75.82% |
| 2012 Q3 | 9.2 Million PLN | 32.52% |
| 2012 Q4 | 16.42 Million PLN | 78.43% |
| 2012 Q2 | 6.94 Million PLN | 0.0% |
| 2012 FY | 61.45 Million PLN | 36.33% |
| 2011 FY | 45.07 Million PLN | 45.29% |
| 2010 FY | 31.02 Million PLN | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Adiuvo Investments S.A. | 990 Thousand PLN | -63010.77% |
| Genomtec S.A. | 1000.00 PLN | -62479562.0% |
| Medinice S.A. | 225 Thousand PLN | -277587.387% |
| Medicalgorithmics S.A. | 43.09 Million PLN | -1349.711% |